BETHESDA, Md., Sept. 17 United BioSource Corporation (UBC)today announced the acquisition of Caro Research, Inc., a leading provider ofsimulation technologies that help pharmaceutical and life science companiesassess costs and benefits associated with health care. With extensiveknowledge of cost data sources and population databases, Caro's team hasestablished methods of collecting, handling and analyzing cost and clinicaldata to support the development and commercialization of drugs, devices,diagnostics and procedures. The acquisition of Caro Research continues UBC'scommitment to invest in technology and scientific leadership to support itsclients in meeting the increasing requirements for real-world evidence.
(Logo: http://www.newscom.com/cgi-bin/prnh/20070910/NEM007LOGO )
"Caro Research is the unquestioned leader in simulation modeling appliedto the issues of value and safety of medical products," said UBC's CEO EthanLeder. "These techniques, at the forefront of health care decision making,give innovative companies the ability to project how their product willperform in the real world from both an economic and clinical perspective."Leder continued, "We are proud to have Dr. Caro and his team of distinguishedscientists and technologists join our health care analytics team. In additionto leading-edge scientific capability, Caro Research expands our scientificpresence in the European, Canadian and Latin American markets."
"UBC is an ideal fit with the mission and capabilities of Caro Research,"said Jaime Caro, MD, founder and CEO of Caro Research. "Our organizations knowand respect each other from working collaboratively on many projects.Together, we can capitalize on UBC's reach, resources and scientific expertiseto meet the exploding demand for our technology, analytical and dataservices."
Dr. Caro will be responsible for the scientific and strategic direction ofUBC's health economics services. Together with Caro Research, UBC's globalhealth care analytics and data services will have a presence in the UnitedStates, Belgium, Canada, Colombia, Czech Republic, Germany, Hungary, Spain,Sweden and the United Kingdom.
Since 1993, Caro Research, Inc., headquartered in Concord, Massachusetts,has been the premier provider of complex modeling techniques, includingdiscrete event simulation (DES). Its multi-national staff is comprised ofinvestigators in medicine, epidemiology, economics, biostatistics, informaticsand health care policy. For more information, visithttp://www.caroresearch.com.
United BioSource Corporation (UBC) is a global pharmaceutical servicesorganization that helps emerging and established life science companiesdevelop and commercialize medical products. UBC specializes in new andinnovative ways to study drugs and devices by offering expertise in science,strategy and execution.
UBC is headquartered in Bethesda, Maryland, with offices located in theUnited States, Canada, Europe, and South America. For more information, visithttp://www.unitedbiosource.com or call 866-458-1096.
Tess Drahzal +1 (240) 644-0420; email@example.com
SOURCE United BioSource Corporation